title: Papillomaviruses: Viral evolution, cancer and evolutionary medicine.
abstract: Papillomaviruses (PVs) are a numerous family of small dsDNA viruses infecting virtually all mammals. PVs cause infections without triggering a strong immune response, and natural infection provides only limited protection against reinfection. Most PVs are part and parcel of the skin microbiota. In some cases, infections by certain PVs take diverse clinical presentations from highly productive self-limited warts to invasive cancers. We propose PVs as an excellent model system to study the evolutionary interactions between the immune system and pathogens causing chronic infections: genotypically, PVs are very diverse, with hundreds of different genotypes infecting skin and mucosa; phenotypically, they display extremely broad gradients and trade-offs between key phenotypic traits, namely productivity, immunogenicity, prevalence, oncogenicity and clinical presentation. Public health interventions have been launched to decrease the burden of PV-associated cancers, including massive vaccination against the most oncogenic human PVs, as well as systematic screening for PV chronic anogenital infections. Anti-PVs vaccines elicit protection against infection, induce cross-protection against closely related viruses and result in herd immunity. However, our knowledge on the ecological and intrapatient dynamics of PV infections remains fragmentary. We still need to understand how the novel anthropogenic selection pressures posed by vaccination and screening will affect viral circulation and epidemiology. We present here an overview of PV evolution and the connection between PV genotypes and the phenotypic, clinical manifestations of the diseases they cause. This differential link between viral evolution and the gradient cancer-warts-asymptomatic infections makes PVs a privileged playground for evolutionary medicine research.
authors: Infections and Cancer Laboratory, Catalan Institute of Oncology (ICO), Barcelona, Spain; Bellvitge Institute of Biomedical Research (IDIBELL), Barcelona, Spain Infections and Cancer Laboratory, Catalan Institute of Oncology (ICO), Barcelona, Spain; Bellvitge Institute of Biomedical Research (IDIBELL), Barcelona, Spain Infections and Cancer Laboratory, Catalan Institute of Oncology (ICO), Barcelona, Spain; Bellvitge Institute of Biomedical Research (IDIBELL), Barcelona, Spain igbravo@iconcologia.net.
authors: Ignacio G
authors: IG
authors: Bravo
authors: Infections and Cancer Laboratory, Catalan Institute of Oncology (ICO), Barcelona, Spain; Bellvitge Institute of Biomedical Research (IDIBELL), Barcelona, Spain Infections and Cancer Laboratory, Catalan Institute of Oncology (ICO), Barcelona, Spain; Bellvitge Institute of Biomedical Research (IDIBELL), Barcelona, Spain.
authors: Marta
authors: M
authors: Félez-Sánchez
keywords: HPV; infection and cancer; molecular epidemiology; screening; vaccination; viral oncology; virus ecology cancer; virus evolution
references: Nucleic Acids Res. 1983 May 11;11(9):2639-50
references: 6304656
references: Nat Rev Cancer. 2002 Jan;2(1):59-65
references: 11902586
references: J Virol. 1983 Aug;47(2):363-6
references: 6312071
references: Lancet Infect Dis. 2014 Oct;14(10):958-66
references: 25107680
references: J Pathol. 2012 May;227(1):62-71
references: 22127961
references: J Invest Dermatol. 1972 Jun;58(6):366-8
references: 4337863
references: Int J Cancer. 2011 Dec 1;129(11):2643-50
references: 21630257
references: J Clin Microbiol. 2003 Jun;41(6):2509-14
references: 12791874
references: J Virol. 2007 Dec;81(24):13280-90
references: 17898069
references: Int J Cancer. 1997 Nov 27;73(5):621-4
references: 9398035
references: Ann N Y Acad Sci. 2011 Aug;1230:1-3
references: 21824161
references: J Infect Dis. 2012 Jan 15;205(2):272-9
references: 22090448
references: J Gen Virol. 2010 Aug;91(Pt 8):2068-72
references: 20392894
references: Virology. 2007 Aug 1;364(2):355-61
references: 17412385
references: J Infect Dis. 2013 Aug 1;208(3):394-402
references: 23599315
references: J Virol. 1996 Mar;70(3):1912-22
references: 8627717
references: Lancet Oncol. 2010 Nov;11(11):1048-56
references: 20952254
references: J Gen Virol. 1992 Feb;73 ( Pt 2):423-8
references: 1311363
references: Oncogene. 2008 Feb 14;27(8):1071-8
references: 17704805
references: J Infect Dis. 2013 Feb 15;207(4):583-7
references: 23204170
references: J Pathol. 1991 Nov;165(3):243-6
references: 1662265
references: J Clin Microbiol. 2014 Feb;52(2):449-59
references: 24478473
references: Ann N Y Acad Sci. 2011 Aug;1230:74-107
references: 21824167
references: Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20458-63
references: 19920181
references: Infect Genet Evol. 2008 Sep;8(5):689-92
references: 18675939
references: Genome Biol Evol. 2014 Jan;6(1):94-104
references: 24391150
references: J Infect Dis. 2010 Dec 1;202(11):1667-70
references: 20977339
references: Obstet Gynecol. 2003 Apr;101(4):645-52
references: 12681865
references: Virology. 2003 Sep 30;314(2):572-9
references: 14554085
references: Pediatrics. 2012 Aug;130(2):e249-56
references: 22778297
references: PLoS One. 2013 Nov 13;8(11):e80583
references: 24236186
references: J Infect Dis. 2012 Jan 1;205(1):72-81
references: 22058418
references: Vaccine. 2012 Nov 20;30 Suppl 5:F55-70
references: 23199966
references: Lancet. 2003 Oct 4;362(9390):1160
references: 14550719
references: Am J Surg Pathol. 2013 Sep;37(9):1299-310
references: 24076770
references: Mol Biol Evol. 2010 Jun;27(6):1301-14
references: 20093429
references: PLoS Pathog. 2013;9(7):e1003321
references: 23853576
references: Virus Genes. 2002 Jun;24(3):275-90
references: 12086149
references: Virus Genes. 2007 Jun;34(3):249-62
references: 16927128
references: J Infect Dis. 2014 Sep 15;210(6):837-45
references: 24740630
references: J Virol. 2010 Oct;84(19):9733-48
references: 20660197
references: J Virol. 1991 May;65(5):2254-60
references: 1850010
references: J Virol. 1997 Oct;71(10):7167-79
references: 9311789
references: J Biol Chem. 1999 Feb 26;274(9):5810-22
references: 10026203
references: J Infect Dis. 1995 Sep;172(3):747-55
references: 7658068
references: Nature. 2014 Feb 20;506(7488):371-5
references: 24390348
references: J Mol Biol. 1992 Nov 5;228(1):1-6
references: 1333015
references: Virology. 2013 Oct;445(1-2):99-114
references: 23731971
references: Sex Transm Infect. 1998 Oct;74(5):349-53
references: 10195031
references: J R Soc Interface. 2007 Oct 22;4(16):787-802
references: 17426010
references: J Med Virol. 2011 Aug;83(8):1345-50
references: 21678438
references: Clin Dermatol. 1997 May-Jun;15(3):369-76
references: 9255443
references: Virology. 2013 Oct;445(1-2):205-12
references: 23953230
references: Sci Rep. 2014 Jul 24;4:5807
references: 25055967
references: J Infect Dis. 2001 Dec 15;184(12):1508-17
references: 11740725
references: PLoS One. 2008 Aug 13;3(8):e2947
references: 18698362
references: Virology. 2012 Jun 5;427(2):189-97
references: 22386054
references: Nature. 2007 Mar 8;446(7132):153-8
references: 17344846
references: J Infect Dis. 2011 Apr 1;203(7):910-20
references: 21402543
references: J Infect Dis. 2014 Aug 15;210(4):517-34
references: 24610876
references: J Infect Dis. 2009 Apr 1;199(7):926-35
references: 19236279
references: Virology. 2009 Oct 25;393(2):304-10
references: 19716580
references: J Virol. 1997 Jul;71(7):5161-72
references: 9188583
references: Am J Epidemiol. 2010 Apr 1;171(7):817-25
references: 20231211
references: Virus Res. 2003 Dec;98(2):95-104
references: 14659556
references: Trends Microbiol. 2005 Nov;13(11):514-21
references: 16181783
references: Lancet. 2004 Nov 13-19;364(9447):1757-65
references: 15541448
references: Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):101-6
references: 11219765
references: Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13
references: 16949996
references: Trends Microbiol. 2010 Oct;18(10):432-8
references: 20739182
references: Virus Genes. 2010 Jun;40(3):329-40
references: 20157772
references: Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
references: 23199955
references: Virology. 2005 Jun 20;337(1):76-84
references: 15914222
references: BMC Infect Dis. 2009 May 27;9:74
references: 19473489
references: J Pathol. 1999 Sep;189(1):12-9
references: 10451482
references: PLoS One. 2013 Nov 11;8(11):e80382
references: 24244682
references: J Virol. 1992 Oct;66(10):5714-25
references: 1326639
references: J Oral Pathol Med. 1991 Aug;20(7):325-31
references: 1654423
references: J Gen Virol. 2014 Dec;95(Pt 12):2748-56
references: 25185436
references: J Virol. 2010 May;84(10):5448-53
references: 20200246
references: Arch Virol. 2005 Feb;150(2):231-46
references: 15503216
references: Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10516-21
references: 22689991
references: Mol Biol Evol. 2010 Sep;27(9):2038-51
references: 20363828
references: Clin Cancer Res. 2002 Sep;8(9):2862-9
references: 12231528
references: J Anat. 2009 Apr;214(4):587-606
references: 19422430
references: J Virol. 1998 Jun;72(6):5016-24
references: 9573271
references: J Virol. 2014 Jul;88(13):7307-16
references: 24741079
references: Virology. 2004 Aug 15;326(1):57-66
references: 15262495
references: Virology. 2004 Jun 20;324(1):17-27
references: 15183049
references: J Vet Diagn Invest. 1992 Jan;4(1):70-4
references: 1313306
references: J Infect Dis. 2002 Aug 15;186(4):462-9
references: 12195372
references: Vaccine. 2012 Nov 20;30 Suppl 5:F83-7
references: 23199968
references: J Gen Virol. 1994 Sep;75 ( Pt 9):2271-6
references: 7521393
references: Nature. 1971 Jul 2;232(5305):51-2
references: 4933174
references: BMC Cancer. 2014 May 30;14:384
references: 24885011
references: Virology. 2010 May 25;401(1):70-9
references: 20206957
references: Virus Res. 2009 Sep;144(1-2):117-22
references: 19379784
references: Int J Cancer. 2011 Mar 1;128(5):1114-9
references: 20839258
references: J Natl Cancer Inst. 1994 Apr 6;86(7):494-9
references: 8133532
references: J Infect Dis. 2011 Dec 15;204(12):1886-92
references: 22013227
references: Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1654-8
references: 7878034
references: Syst Biol. 2003 Feb;52(1):37-47
references: 12554438
references: Virology. 1997 Oct 27;237(2):296-306
references: 9356341
references: Vaccine. 2013 Feb 6;31(8):1238-45
references: 23246257
references: J Virol Methods. 2008 Mar;148(1-2):34-9
references: 18061687
references: Clin Infect Dis. 2013 May;56(10):1451-6
references: 23392393
references: Int J Cancer. 2005 Jan 10;113(2):276-83
references: 15386416
references: J Infect Dis. 2009 Apr 1;199(7):936-44
references: 19236277
references: J Virol. 2000 Dec;74(24):11636-41
references: 11090162
references: J Virol. 2005 Dec;79(24):15503-10
references: 16306621
references: J Infect Dis. 2010 Dec 15;202(12):1789-99
references: 21067372
references: Genes Dev. 1995 Oct 1;9(19):2335-49
references: 7557386
references: Genome Biol. 2007;8(4):R57
references: 17430578
references: J Infect Dis. 2014 Mar;209(6):855-64
references: 24179110
references: PLoS One. 2010 Sep 17;5(9):null
references: 20862247
references: Virology. 2008 Aug 15;378(1):151-61
references: 18579177
references: J Clin Virol. 2005 Mar;32 Suppl 1:S7-15
references: 15753007
references: Microbiol Mol Biol Rev. 2004 Jun;68(2):362-72
references: 15187189
references: J Virol. 2012 Jan;86(1):94-107
references: 22013048
references: J Gen Virol. 2012 Jun;93(Pt 6):1362-6
references: 22422067
references: Dermatology. 2003;207(3):251-4
references: 14571065
references: J Invest Dermatol. 2009 Oct;129(10):2427-34
references: 19516265
references: Mol Biol Evol. 2011 Jul;28(7):2101-13
references: 21285031
references: Science. 2008 Apr 11;320(5873):230-3
references: 18403710
references: J Clin Microbiol. 2000 Sep;38(9):3388-93
references: 10970388
references: J Clin Microbiol. 1995 Nov;33(11):2957-62
references: 8576353
references: Clin Dermatol. 2014 Mar-Apr;32(2):253-8
references: 24559561
references: Virology. 2003 Mar 1;307(1):1-11
references: 12667809
references: Vaccine. 2006 Aug 31;24 Suppl 3:S3/52-61
references: 16950018
references: Am J Epidemiol. 2013 Aug 15;178(4):625-34
references: 23660798
references: J Virol. 2003 Apr;77(8):4928-37
references: 12663798
references: N Engl J Med. 2012 Sep 27;367(13):1220-7
references: 23013073
references: Science. 1989 Feb 17;243(4893):934-7
references: 2537532
references: J Virol. 2012 Jun;86(12):6855-61
references: 22491459
references: J Virol. 2002 Oct;76(19):10009-14
references: 12208977
references: Mol Cell Biol. 1986 Oct;6(10):3349-56
references: 3540589
references: J Infect Dis. 2011 Aug 1;204(3):385-90
references: 21742837
references: J Virol. 1999 Jun;73(6):4972-82
references: 10233959
references: Trends Microbiol. 1994 Mar;2(3):76-81
references: 8156275
references: J Virol. 2014 May;88(9):4786-97
references: 24522917
references: J Virol. 2004 Dec;78(24):13613-26
references: 15564472
references: Emerg Infect Dis. 2004 Jan;10(1):8-13
references: 15078590
references: Virology. 2009 Nov 10;394(1):8-11
references: 19758676
references: Int J Cancer. 2015 Jan 1;136(1):98-107
references: 24817381
references: Lancet. 2014 Dec 20;384(9961):2213-27
references: 25189358
references: PLoS One. 2013 Aug 29;8(8):e72088
references: 24009669
references: Nat Rev Genet. 2008 Apr;9(4):267-76
references: 18319742
references: Curr Top Microbiol Immunol. 1994;186:33-54
references: 8205845
references: Virology. 2013 Oct;445(1-2):187-96
references: 23706315
references: BMC Evol Biol. 2006 Mar 09;6:20
references: 16526953
references: J Virol. 1993 Nov;67(11):6424-31
references: 8411344
references: PLoS Pathog. 2008 Jun 20;4(6):e1000091
references: 18566657
references: Mol Biol Evol. 2007 May;24(5):1242-58
references: 17344207
references: J Theor Biol. 2014 Jun 7;350:98-109
references: 24412334
references: J Virol. 2002 Dec;76(24):12537-42
references: 12438579
references: Virology. 2012 Nov 25;433(2):385-94
references: 22985477
references: Lancet Oncol. 2005 May;6(5):271-8
references: 15863374
references: Trends Microbiol. 2011 Jan;19(1):24-32
references: 21055948